Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of remimazolam in elderly patients undergoing upper gastrointestinal endoscopy
ChiCTR2000034234Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Hainan Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in None (3 arms), sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoints: Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score, Non-invasive blood pressure (NBP) and 5 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000034234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034234.